Scientists have been trying to figure out how to eradicate malaria for decades. Globally, a child under the age of five dies from the disease every two minutes, and even for kids who do survive there can be long term complications. A big breakthrough finally came in October when the World Health Organization endorsed MoSQUIRIX, the first malaria vaccine. It has relatively low efficacy, just about 30%, but malaria researcher
Winter Okoth explains how the new vaccine could still make a big difference.
To manage podcast ad preferences, review the links below:
See
pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
Learn more about sponsor message choices:
podcastchoices.com/adchoicesNPR Privacy Policy